Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema

NCT00375713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

466

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis
Eczema

Interventions

DRUG: Levocetirizine
DRUG: Cetirizine
DRUG: Placebo-Levocetirizine
DRUG: Placebo-Cetirizine
DRUG: Standard topical steroid (1% hydrocortisone) ointment

Sponsor

UCB Pharma